Transplant in the Elderly Population
February 9th 2024This session will focus on considerations and outcomes of allo-HSCT specifically among patients over 55 years of age. The panel will discuss how transplant protocols and supportive care measures can be optimized for this population who are at higher risk of comorbidities, toxicity and poor functional status.
Read More
Supportive Care Measures for Patients Planning to Receive an Allogenic Transplant
January 19th 2024This presentation will detail the supportive therapies and interventions provided to patients before, during, and after undergoing allo-HSCT. The speaker will also discuss management of treatment side effects and comorbidities to optimize patient outcomes.
Read More
Hematologic Malignancies and Transplant Options and Conditioning Regimens Used in Allo-HSCT
January 19th 2024Delve into the pre-transplant conditioning regimens such as chemotherapy and radiation used to prepare and immunosuppress patients to prevent graft rejection prior to allogeneic hematopoietic stem cell transplantation.
Read More